Chronic pain and risk of cognitive impairment: a meta-analysis of longitudinal cohort studies
Abstract
Chronic pain is increasingly recognized as a potential risk factor for cognitive decline, yet findings from observational studies are inconsistent. We conducted a meta-analysis to evaluate the long-term association between chronic pain and cognitive impairment. PubMed, Embase, and the Cochrane Library were searched from inception to January 2025 for longitudinal cohort studies assessing this relationship. Twenty-eight eligible cohorts comprising 7,914,407 participants were included. Adjusted odds ratios (ORs) were pooled using random-effects models; subgroup, sensitivity, and meta-regression analyses were performed to explore heterogeneity. Chronic pain was associated with a higher risk of cognitive impairment (pooled adjusted OR = 1.30; 95% CI: 1.14-1.47), an effect driven by dementia (pooled OR = 1.43; 95% CI: 1.23-1.65) rather than by global cognitive performance scores (pooled OR = 0.99; 95% CI: 0.88-1.11). Associations were stronger in studies with follow-up ≥5 years (OR = 1.37), in older populations (OR = 1.30), and in cohorts focusing on headache-related pain (OR = 1.42). Meta-regression indicated that depression was a key moderator of the association. These findings suggest that chronic pain is linked specifically to an increased risk of dementia, particularly among older individuals and those with headache-related pain. Integrative clinical strategies addressing pain and co-occurring depression, along with mechanistic and interventional studies using standardized…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 7,914,407 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.